WOUNDTEK, INC ANNOUNCES NEW DISTRIBUTION AGREEMENT WITH TECH-MEDICAL SERVICES, INC.

NEWPORT, RI, December 2, 2005 – WoundTEK, Inc., a privately held medical device company, announced today that has entered into an exclusive agreement with Tech Medical Services of Nixa, Missouri to market and distribute it’s leading wound closure device throughout Missouri, Kansas, Nebraska, Oklahoma, Iowa, and Southern Illinois.

The Agreement allows Tech Medical to exclusively market and sell the S.T.A.R. device into this vast region. The S.T.A.R., (Suture Tension Adjustment Reel) is the first minimally invasive tissue expansion device for the closure of large open wounds caused by trauma and surgery.

"We are very happy to welcome Tech-Medical to our family of distributors. They have been selling specialty medical products to surgical hospitals in their market for a very long time and have 7 very seasoned sales people that have relationships with dozens of hospitals and health care facilities. It represents a very large opportunity for us to grow our awareness and our market share rapidly.” Said Andrew Reilly, WoundTEK, Inc. Chief Executive.

“Tech- Medical helps medical device companies create new product markets. The opportunity that the S.T.A.R. device represents is very large and I think that we can help WoundTEK become a dominant player in the wound closure space” Ken Anderson, Tech- Medicals’ Founder and President said. He continued, “Our success as a company depends on our ability to introduce the latest medical technology to our customers. The surgeons and hospitals needs are our main focus and we think the S.T.A.R. device will be very well received.”

Tech-Medical is a regional medical device sales company, covering six states and is a privately held company. Tech Medicals’ charter is to create strong sales and marketing programs for highly specialized O.R. products targeted to specialty surgeons within the middle states of the USA.

WoundTEK, Inc based in Newport, RI is a medical device company focused on the closure of large wounds and skin deficits caused by trauma or surgery. The company manufactures The S.T.A.R. Device. The first minimally invasive tissue expansion device, The S.T.A.R. brings to closure large wounds that cannot be closed using primary closure methods. The S.T.A.R. is a simple, effective and proven method of closing large wounds. Comprised of a winder reel and an anchor mechanism joined by a simple mattress suture, The S.T.A.R. is able to rapidly expand tissue across large skin deficits with very little discomfort, closing large wounds faster and raising the level of patient care.

Large wound closure is a major health care problem worldwide and is one of the leading causes of deadly infections in the United States. Almost 2,00,000 trauma cases and surgical procedures each year are faced with the challenge of closing large wounds and skin deficits. Current procedures to close large wounds can be technically demanding, increase the risk of infection, and be very invasive, painful, and have deep scaring effects to the tissue. The S.T.A.R. System reduces many of the challenges that are currently faced by surgeons today.

# # #

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements are necessarily estimates reflecting the best judgment of our management and involve a number of risks and uncertainties that could cause actual results to differ materially from those suggested by the forward-looking statements. These forward-looking statements should, therefore, be considered in light of various important factors, including the following: timing and success of product development and market acceptance of developed products; regulatory approvals, clearances and restrictions; guidelines and recommendations in the health care and patient communities; intellectual property positions and litigation; competition in the medical device industry and in the specific markets of surgery in which WoundTEK operates; unanticipated manufacturing disruptions, delays in regulatory approvals of new manufacturing facilities or the inability to meet demand for products. Words such as "estimate," "project," "plan," "intend," "expect," "anticipate," "believe" and similar expressions are intended to identify forward-looking statements. You are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this press release. We undertake no obligation to publicly update or release any revisions to these forward-looking statements to reflect events or circumstances after the date of this press release or to reflect the occurrence of unanticipated events.